In a later study by the same group, serum VEGF levels significantly decreased from baseline over a follow-up period of up to 8 weeks in 6 patients with ROP after IVB, while there was no significant difference in 4 patients who underwent intravitreal ranibizumab (IVR) treatment5. This evidence concerns the gene VEGFA and retinopathy of prematurity.